We demonstrated that, in distinction to classical opioid receptors, ACKR3 does not set off classical G protein signaling and is not modulated via the classical prescription or analgesic opioids, like morphine, fentanyl, or buprenorphine, or by nonselective opioid antagonists such as naloxone. Instead, we established that LIH383, an ACKR3-selective https://alexisk495dul1.theobloggers.com/profile